Evolution of psycho-behavioural disorders of exposed subjects over three years follow up
| 1st assessment (n = 202) | 3 months (n = 182) | 1 year (n = 175) | 2 years (n = 162) | 3 years (n = 151) | |
|---|---|---|---|---|---|
| *GHQ assessments excluded because outside the timeframe. | |||||
| MINI | |||||
| At least 1 diagnosis | 11% | 7% | 4.5% | 4.3% | 4% |
| incl. 3 new | incl. 2 new | incl. 1 new | |||
| Severe depression | 1.5% | 0 | 0 | 0 | 0 |
| Dysthymia | 1.0% | 1.1% | 0.6% | 0.6% | 0.7% |
| Panic disorder | 0.5% | 1.1% | 0.6% | 0 | 0 |
| Manic episode | 0.5% | 0 | 0 | 0 | 0 |
| Generalised | 4.0% | 3.3% | 1.1% | 1.9% | 2.6% |
| 1 acute life event | 1 acute life event | ||||
| GAD | |||||
| Bulimia/anorexia | 0 | 0 | 0.6% | 0 | 0 |
| Agoraphobia | 2.5% | 2.2% | 0.6% | 0.6% | 0 |
| Social phobia | 1.5% | 0.5% | 0.6% | 0.6% | 0.7% |
| OCD | 0 | 0 | 0 | 0 | 0 |
| Alcoholism | 1.5% | 1.6% | 1.1% | 0 | 0.7% |
| Psychotic syndromes | 0 | 0 | 0 | 0 | 0 |
| PTSD | 4.0% | 1.6% | 0.6% | 0.6% | 0 |
| 1 new person acci. | |||||
| Somatic symptoms | 0.5% | 1.1% | 0 | 0 | 1.3% |
| GHQ-28 | n = 198* | n = 182 | n = 134* | n = 121* | n = 109* |
| Score ⩾5 | 32% | 5.5% | 2.2% | 7.4% | 3.7% |
| Sub-score (average) | |||||
| Somatic symptoms | 4.3±3.4 | 2.9±2.6 | 2.8±2.2 | 3.0±2.6 | 2.9±2.4 |
| Anxiety/insomnia | 4.9±4.2 | 2.8±2.8 | 3.1±2.9 | 3.3±3.3 | 3.2±2.7 |
| Social dysfunction | 7.3±1.6 | 7.0±1.2 | 6.9±0.7 | 7.0±1.2 | 7.0±0.7 |
| Depression | 0.9±1.8 | 0.9±2.0 | 0.7±1.5 | 0.7±1.9 | 0.6±1.4 |
| Psychosocial functioning | n = 202 | n = 182 | n = 175 | n = 162 | n = 151 |
| <80 | 7% | 4.4% | 1.7% | 2.5% | 1.3% |
| Stress factors | n = 202 | n = 182 | n = 175 | n = 162 | n = 151 |
| Acute | 15% | 9.3% | 11.4% | 16% | 10.6% |
| Sustained | 14% | − | 7.4% | 13% | 10.6% |
| Psychotropic treatments | n = 202 | n = 182 | n = 175 | n = 162 | n = 151 |
| Psychotropic treatments | 6% | 1.1% | 2.9% | 3.1% | 0.7% |
| Psychological follow up | n = 202 | n = 182 | n = 175 | n = 162 | n = 151 |
| Psychological follow up | 0 | 2.2% | 1.1% | 1.9% | 1.3% |
| Somatic examination | n = 202 | n = 182 | n = 175 | n = 162 | n = 151 |
| Abnormal somatic examination | 5.5% | 3% | 6% | 4% | 11% |